BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1101 related articles for article (PubMed ID: 18544264)

  • 1. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphincter preservation therapy for rectal cancer.
    Aitken C; Breen E; Mamon HJ
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):735-40. PubMed ID: 16258478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saving the sphincter in rectal cancer: are we prepared to change practice?
    Wallace MH; Glynne-Jones R
    Colorectal Dis; 2007 May; 9(4):302-8; discussion 308-9. PubMed ID: 17432980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer.
    Gavioli M; Luppi G; Losi L; Bertolini F; Santantonio M; Falchi AM; D'Amico R; Conte PF; Natalini G
    Dis Colon Rectum; 2005 Oct; 48(10):1851-7. PubMed ID: 16132481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
    Berardi R; Mantello G; Scartozzi M; Del Prete S; Luppi G; Martinelli R; Fumagalli M; Grillo-Ruggieri F; Bearzi I; Mandolesi A; Marmorale C; Cascinu S
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1437-43. PubMed ID: 19386440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.
    de Campos-Lobato LF; Stocchi L; da Luz Moreira A; Geisler D; Dietz DW; Lavery IC; Fazio VW; Kalady MF
    Ann Surg Oncol; 2011 Jun; 18(6):1590-8. PubMed ID: 21207164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of preoperative concurrent chemoradiotherapy in locally advanced low rectal cancer after radical resection surgery.
    Lam CW; Chen WT; Liu MT; Chang CS; Huang TM; Hsu GH; Chen HC; Hsiao KH; Chiu CM; You JJ
    Int Surg; 2005; 90(1):53-9. PubMed ID: 15912902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge.
    Kim DW; Lim SB; Kim DY; Kim TH; Jung KH; Kim DH; Chang HJ; Sohn DK; Hong CW; Choi HS; Jeong SY; Park JG
    Eur J Surg Oncol; 2006 Mar; 32(2):162-7. PubMed ID: 16289718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and imaging of low rectal carcinoma.
    Salerno G; Daniels I; Heald RJ; Brown G; Moran BJ
    Surg Oncol; 2004; 13(2-3):55-61. PubMed ID: 15572087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
    Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
    J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
    Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
    Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversial aspects of rectal cancer surgery following preoperative chemoradiation.
    Artioukh DY
    Colorectal Dis; 2010 Aug; 12 Suppl 2():25-9. PubMed ID: 20618364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers of local relapse in rectal cancer: are we any further forward?
    Johnston PG
    J Clin Oncol; 2006 Sep; 24(25):4049-50. PubMed ID: 16943520
    [No Abstract]   [Full Text] [Related]  

  • 17. Rectal cancer.
    Legoux JL; Lehur PA; Penna C; Calais G; Roseau G; Calan LD
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S43-2S51. PubMed ID: 17151562
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of neoadjuvant radio-chemotherapy in the treatment of rectal cancer].
    Staudacher C; Di Palo S; Tamburini AM; Vignali A; Orsenigo E
    Ann Ital Chir; 2007; 78(6):493-8. PubMed ID: 18510028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polyradiomodification as component of combined treatment of rectal cancer: rationale and results].
    Barsukov IuA; Tkachev SI; Oltarzhevskaia ND; Perevoshchikov AG; Korovina MA; Nikolaev AV; Glebovskaia VV; Kuz'michev DV; Aliev VA; Mamedli ZZ; Pavlova AM
    Vopr Onkol; 2010; 56(1):66-9. PubMed ID: 20361619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.